Premium
LOW LEVELS OF IMMUNO‐SUPPRESSOR CELLS PROMOTE RESPONSES TO A HAPLOIDENTICAL NATURAL KILLER CELL THERAPY AND INDUCE REMISSIONS IN NON‐HODGKIN LYMPHOMA
Author(s) -
Bachanova V.,
Sarhan D.,
Defor T.,
Cooley S.,
PanoskaltsisMortari A.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2438_130
Subject(s) - medicine , lymphoma , immunology , immune system , cytokine release syndrome , tolerability , rituximab , oncology , gastroenterology , immunotherapy , adverse effect , chimeric antigen receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom